| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/11/2011 | CN101361917B Traditional Chinese medicine preparation for enhancing immunity and promoting sleep |
| 05/11/2011 | CN101361916B Traditional Chinese medicine preparation for enhancing immunity and promoting sleep |
| 05/11/2011 | CN101361876B Wound-healing tissue-promoting powder and preparation method thereof |
| 05/11/2011 | CN101361873B Blood-activating emergency paste and preparation method thereof |
| 05/11/2011 | CN101348786B Human beta-globin gene and recombinant adenovirus related virus vector thereof |
| 05/11/2011 | CN101347514B Health medical pillow |
| 05/11/2011 | CN101342363B Preparation of sedative and brain-invigorating oral liquid |
| 05/11/2011 | CN101342317B Medicament composition for treating tuberculosis and preparation method thereof |
| 05/11/2011 | CN101337018B Traditional Chinese medicine for treating cheilitis and preparation method thereof |
| 05/11/2011 | CN101301411B Chinese medicinal composition for treating angina pectoris |
| 05/11/2011 | CN101301379B Chinese medicinal composition and preparation and use thereof |
| 05/11/2011 | CN101300341B Lactic acid bacterium having immunoregulatory activity derived from moromi for wine fermentation |
| 05/11/2011 | CN101274060B Loins-strengthening and kidney-invigorating paste |
| 05/11/2011 | CN101254276B Enema for curing radioactivity rectitis |
| 05/11/2011 | CN101234174B Liquid medicine for treating corn and onychomycosis |
| 05/11/2011 | CN101204456B Marinating medicine for hands and feet psoriasis |
| 05/11/2011 | CN101199648B Chinese medicine agent for treating chronicity tonsillitis |
| 05/11/2011 | CN101152243B Traditional Chinese medicine for treating apoplexy and technique of preparing the same |
| 05/11/2011 | CN101129405B Biological formulation product for treating habitual abortion |
| 05/11/2011 | CN101085283B Vein relaxing externally used lotion for dermatosis |
| 05/11/2011 | CN101082026B Preparation of holothurian-nourishing bacterium and method for restoring sea cucumber cultivation pool environment |
| 05/11/2011 | CN101082025B Preparation of holothurian-protecting bacterium and method for restoring sea cucumber cultivation pool environment |
| 05/11/2011 | CN101036706B Wine for promoting blood circulation, removing blood stasis and eliminating rheumatism |
| 05/11/2011 | CN101032561B Chinese traditional medicine composition to be taken orally for curing hepatocirrhosis |
| 05/10/2011 | US7939646 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/10/2011 | US7939318 Flexible vaccine assembly and vaccine delivery platform |
| 05/10/2011 | US7939118 Oligosaccharide mixture |
| 05/10/2011 | US7939108 5-20% More demineralized bone particles are obtained by demineralizing whole bone and thereafter subdividing the demineralized bone to provide the demineralized bone particles; pretreating with an acid solution and then pressing to pulverize; surgery; grafting; bone disorders; efficiency |
| 05/10/2011 | US7939107 Emu oil and fruit composition |
| 05/10/2011 | US7939099 Sustained improver of muscular fatigue |
| 05/10/2011 | US7939088 Streptococcus phocae vaccine |
| 05/10/2011 | US7939085 Attenuated myxomavirus that has lost receptor properties of myxomavirus interferon receptor or myxomavirus tumor necrosis factor receptor or myxomavirus interleukin receptor; causes an increase in number of leukocytes in human patient 7 days after administration |
| 05/10/2011 | US7939073 Immunotherapy of B-cell malignancies using anti-CD22 antibodies |
| 05/10/2011 | US7939071 Artery- and vein-specific proteins and uses therefor |
| 05/10/2011 | US7939066 Methods and compositions for the inhibition of growth of infectious Aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species |
| 05/10/2011 | US7939063 Delivery vehicle for recombinant proteins |
| 05/10/2011 | US7939062 Methods for human allografting |
| 05/10/2011 | US7939060 Equol-containing composition comprising daidzein for use in prevention and treatment of bone disorders |
| 05/10/2011 | CA2457057C Compositions and methods for treating neurodegenerative diseases |
| 05/10/2011 | CA2406664C Systemic delivery of neural stem cells to treat cancer |
| 05/10/2011 | CA2363712C Long lasting insulinotropic peptides |
| 05/10/2011 | CA2361249C Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 05/10/2011 | CA2300260C Galactosidase modified submucosal tissue |
| 05/09/2011 | CA2720567A1 Transgenic non-human animal and methods for stem cell engraftment |
| 05/05/2011 | WO2011053860A2 Mesenchymal stromal cell populations and methods of using same |
| 05/05/2011 | WO2011053653A2 Prevotella histicola preparations and the treatment of autoimmune conditions |
| 05/05/2011 | WO2011053322A1 Use of autologous effector cells and antibodies for treatment of multiple myeloma |
| 05/05/2011 | WO2011053321A1 Use of autologous effector cells for treatment of multiple myeloma |
| 05/05/2011 | WO2011052996A2 Novel lactobacillus plantarum and composition comprising the same |
| 05/05/2011 | WO2011052818A1 Method for producing mesenchymal stem cells from human pluripotent stem cells, and mesenchymal stem cells produced by same |
| 05/05/2011 | WO2011052771A1 Nebulizable tuberculosis vaccine for transnasal administration comprising paramyxovirus vector |
| 05/05/2011 | WO2011052668A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | WO2011052638A1 Process for production of cytokine-induced killer cells |
| 05/05/2011 | WO2011052281A1 Method for building a nerve spheroid network |
| 05/05/2011 | WO2011051760A1 Method for reducing gastro-intestinal inflammation using bifidobacterium animalis bacteria or a fermented dairy product comprising such bacteria |
| 05/05/2011 | WO2011051346A1 Composition to induce specific immune tolerance |
| 05/05/2011 | WO2011050574A1 Pharmaceutical composition containing cyclometalated n-heterocyclic carbene complexes for cancer treatment |
| 05/05/2011 | WO2011050476A1 Methods for reprogramming cells and uses thereof |
| 05/05/2011 | WO2011050470A1 Generating induced pluripotent stem cells and progenitor cells from fibroblasts |
| 05/05/2011 | WO2011011302A3 Differentiation of human embryonic stem cells |
| 05/05/2011 | WO2011007339A3 Chimeric foot and mouth disease viruses |
| 05/05/2011 | WO2011005306A3 Production of and uses for decellularized lung tissue |
| 05/05/2011 | WO2010146568A3 Bifidobacteria for treating diabetes and related conditions |
| 05/05/2011 | US20110105721 Peptides |
| 05/05/2011 | US20110104299 Bone graft materials derived from mineralized gelatin |
| 05/05/2011 | US20110104298 Universally applicable virus inactivated blood plasma produced from portions of non-Caucasians plasma |
| 05/05/2011 | US20110104297 Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders |
| 05/05/2011 | US20110104292 Medical composition and medical kit |
| 05/05/2011 | US20110104284 Hyaluronic acid derivative based three-dimensional matrix |
| 05/05/2011 | US20110104279 Healing powder and method of use thereof |
| 05/05/2011 | US20110104251 Cosmetic Composition And Method For Retarding Hair Growth |
| 05/05/2011 | US20110104242 Cartilage material |
| 05/05/2011 | US20110104240 Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections |
| 05/05/2011 | US20110104232 Sustained Release Systems of Ascorbic Acid Phosphate |
| 05/05/2011 | US20110104230 Compositions of novel bone patch in bone and vascular regeneration |
| 05/05/2011 | US20110104229 Bone Xenograft |
| 05/05/2011 | US20110104227 Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants |
| 05/05/2011 | US20110104226 Peptides having binding affinity to an antibody which recognizes an epitope on an a1 loop 2 or beta2 loop 1 of an adrenoreceptor |
| 05/05/2011 | US20110104211 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/05/2011 | US20110104210 Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors |
| 05/05/2011 | US20110104199 MVA Expressing Modified HIV Envelope, GAG, and POL Genes |
| 05/05/2011 | US20110104189 Compositions obtained from chlorella extract having immunomodulating properties |
| 05/05/2011 | US20110104167 Compositions and Methods for Diagnosing and Treating Insulin Resistance |
| 05/05/2011 | US20110104136 Natural Killer p30 (NKp30) Dysfunction and the Biological Applications Thereof |
| 05/05/2011 | US20110104134 Novel lactic acid bacterium having high immunoglobulin-a-inducing ability |
| 05/05/2011 | US20110104133 Methods and compositions for inducing brown adipogenesis |
| 05/05/2011 | US20110104131 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 05/05/2011 | US20110104130 Thymidylate kinase fusions and uses thereof |
| 05/05/2011 | US20110104129 T cell receptors and related materials and methods of use |
| 05/05/2011 | US20110104127 mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION |
| 05/05/2011 | US20110104126 Human Hepatic Stem Cell, Method for Preparation of the Same, Method for Induction of Differentiation of the Same, and Method for Utilization of the Same |
| 05/05/2011 | US20110104125 Episomal reprogramming with chemicals |
| 05/05/2011 | US20110104124 Mesodermal-like cell population for treating ischemia in mammals |
| 05/05/2011 | US20110104123 Therapeutic protocol using stem cells in tissue and neuronal repair, maintenance, regeneration and augmentation |
| 05/05/2011 | US20110104122 Efficient production and use of highly cardiogenic progenitors and cardiomyocytes from embryonic and induced pluripotent stem cells |
| 05/05/2011 | US20110104121 Female Reproductive Tract and Anal Prophylaxes |
| 05/05/2011 | US20110104120 Directed Evolution and In Vivo Panning of Virus Vectors |
| 05/05/2011 | US20110104119 Chimeric Vectors |
| 05/05/2011 | US20110104117 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 05/05/2011 | US20110104102 Method for stimulating mammalian cells and mammalian cell |